Navigation Links
XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain
Date:6/30/2008

VALLEY COTTAGE, N.Y., June 30 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB; TASE: XTL) today announced that it has completed patient randomization into its Phase 2b study of Bicifadine -- a serotonin and norepinephrine reuptake inhibitor (SNRI) -- for the treatment of diabetic neuropathic pain. 350 patients were randomized into the study. Based on the completion of randomization, the Company expects to have the last patient complete the study in the next 4 months.

The Phase 2b trial is aimed at demonstrating the efficacy of Bicifadine in diabetic neuropathic pain, using a study design that is similar to the successful registration trials of Cymbalta(R), a member of the SNRI class that is approved for this indication, and other approved agents for neuropathic pain.

The Phase 2b study is a randomized, double-blind, placebo-controlled study comparing 200mg 3x/day (tid) and 400mg 3x/day (tid) of Bicifadine versus placebo, with a 1:1:1 randomization between the three arms, in patients with diabetic neuropathic pain. Approximately 40 clinical centers in the United States, Germany, Israel and India are participating in the study. Following randomization, all patients enter a 2-week titration period to allow them to gradually escalate up to their target treatment dose. This is followed by a 12-week steady-state treatment period at the target treatment dose. The primary endpoint of the study is to compare the efficacy of each of the two active doses of Bicifadine (200mg tid and 400mg tid) versus placebo in reduction of pain associated with diabetic neuropathy, at baseline (at the time of randomization) versus week 14 (week 12 of the steady-state phase). Pain is measured based on a 24-hour pain rating using the
'/>"/>

SOURCE XTL Biopharmaceuticals Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Morria Biopharmaceuticals Plc Announces the Initiation of a Phase II Clinical Multi-dose Study of MRX-4 in Allergic Rhinitis
2. Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX-4 in Allergic Rhinitis
3. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
4. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
5. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
6. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
7. Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial
8. Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
9. XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis
10. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
11. Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... DETROIT , April 17, 2015  In Detroit, ... the infant mortality rate is two and one half times ... births. Nearly 6 of 10 infants that die in ... These are sobering statistics that Covenant Community Care, a faith-based, ... Detroit, is poised to change thanks to a charitable donation ...
(Date:4/17/2015)... DALLAS , Apr. 17, 2015 Steven ... ( ALGA ), and its operating subsidiary American Seed ... an exclusive presentation to investors yesterday in New York ... Strategy. The American Seed & Oil Company ... , Hippie Butter Hemp Seed Foods , the ...
(Date:4/17/2015)... Apr. 16, 2015 Research and Markets ... of the "The Corporate Reputation of Pharma ... Edition " report to their offering. ... Perspective, is now in its fourth edition. This ... early 2015). For each annual Corporate Reputation report, ...
Breaking Medicine Technology:Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 2Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 3Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 4American Seed & Oil Company Benchmarks its Consumer Product Development Strategy Against Proctor & Gamble 2American Seed & Oil Company Benchmarks its Consumer Product Development Strategy Against Proctor & Gamble 3The Corporate Reputation of Pharma - The Global Patient Perspective in 2014 2
... /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR ... worldwide, today announced that it will report its financial results ... U.S. market closes on May 9, 2011. Mindray,s management will ... 10, 2011 U.S. Eastern Time (8:00 PM on May 10, ...
... Corporation (OTCBB: PRTT) today announced its Board of Directors ... its Chief Executive Officer and Chairman of the Board, ... Operating Officer and Board Member in March 2011, following ... was the Founder and CEO. Mr. Sesha ...
Cached Medicine Technology:Mindray to Report First Quarter 2011 Financial Results on May 9, 2011 2Protect Pharmaceutical Corporation Appoints Chief Executive Officer and Chief Financial Officer 2
(Date:4/17/2015)... ERGO-Pedic Products, LLC, which produces therapeutic memory ... to help a broader range of people plagued by ... second most common visitors to doctors. , “The ERGO-Pedic ... help relieve sitting pain. Then, only a couple months ... customers later, we began getting questions from those customers, ...
(Date:4/17/2015)... 2015 Alcohol and Violence , The ... that drinking and driving has been the focus of ... time, the link between alcohol and crime received less ... violence and sexual assault, and their relationship to alcohol ... 5.3 million adults in America were drinking alcohol at ...
(Date:4/17/2015)... have seen healing, a lot of healing, and a lot ... Kafader of Friendship Village. “People have found purpose. ... have created beautiful pieces of art.” For the past eight ... was launched to benefit residents of the retirement community. , ... Institute in Chicago, worked as an intern at Friendship Village, ...
(Date:4/17/2015)... 17, 2015 In Defense of Christians ... statement: “On Wednesday April 15th, the European Parliament joined ... resolution recognizing the Armenian Genocide, “paying tribute, on the ... one-and-a-half million innocent Armenian victims who perished in the ... the EU for this timely and needed recognition of ...
(Date:4/17/2015)... Representatives Jim Himes (D-CT) and Ed Royce ... 1849 in congress on April 16, 2015 in an ... with the genetic disease. , The bill, similar ... first to create a federally led and financed initiative ... telangiectasia. This would effectively prevent premature death and disability ...
Breaking Medicine News(10 mins):Health News:Seat Cushion Company Credits Customer Driven Design For Two New Products 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 3Health News:Healing At Friendship Village Due To Art Therapy 2Health News:In Defense of Christians Condemns Armenian Genocide 2Health News:In Defense of Christians Condemns Armenian Genocide 3Health News:House Representatives Introduce Bill to Fight Genetic Disease 2
... 2010, NEW ORLEANS You expect to find leading experts ... medicine presenting their research at the annual ATS International ... High school students? Not so much. But ... and will graduate from high school on May 28, ...
... at the Queensland Institute of Medical Research (QIMR) and the ... and successfully treated it by performing an experimental stem cell ... and out of hospital Katie Pulling had almost given up ... hearing the doctors say, ,We don,t know what is wrong, ...
... of HIV prevention research will be taking center stage at ... Convention Center in Pittsburgh May 22-25. M2010 will be ... and experts in global health who are working in all ... world. Nearly 1,000 participants from 47 countries will be attending. ...
... ... don’t know what to look for. Flexible Assembly Systems uncovers the great torque screwdriver mystery ... ... be difficult if you don’t know what to look for. A torque screwdriver comes ...
... In study, patients controlled severe disease using less medication ... symptom control might be a mouse click away, Dutch ... monitoring and dosing program maintained long-term control of severe ... oral corticosteroid) to do so, the study found. , ...
... developing brain, researchers say , MONDAY, May 17 (HealthDay ... levels of organophosphate pesticides, commonly found on berries, celery ... disorder (ADHD) in children. , At this point, ... actually cause ADHD, stated the authors of a paper ...
Cached Medicine News:Health News:Challenging the use of routine repeated chest X-rays in certain patients 2Health News:Challenging the use of routine repeated chest X-rays in certain patients 3Health News:Australian researchers identify a new disease 2Health News:Press briefings at International Microbicides Conference May 22-25 2Health News:Press briefings at International Microbicides Conference May 22-25 3Health News:Press briefings at International Microbicides Conference May 22-25 4Health News:Press briefings at International Microbicides Conference May 22-25 5Health News:Flexible Assembly Systems Announces Torque Screwdriver Application Guide 2Health News:Web-Based Program Can Boost Asthma Care 2Health News:Pesticides on Produce Tied to ADHD in Children 2Health News:Pesticides on Produce Tied to ADHD in Children 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: